Evidence map›Paper›PMID 26318452›Full record

ArticleThe Journal of biological chemistry2015

Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.

María José Hernández-Corbacho, Daniel Canals, Mohamad M Adada, Mengling Liu, Can E Senkal, Jae Kyo Yi, Cungui Mao, Chiara Luberto, Yusuf A Hannun, Lina M Obeid

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Proinflammatory cytokines modify CaFrontiers in physiology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. The vascular endothelium as decision maker in lung injury.Frontiers in cell and developmental biology · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

María José Hernández-CorbachoFrom the Stony Brook Cancer Center, the Department of Medicine, and.
Daniel CanalsFrom the Stony Brook Cancer Center, the Department of Medicine, and.
Mohamad M AdadaFrom the Stony Brook Cancer Center, the Department of Medicine, and.
Mengling LiuFrom the Stony Brook Cancer Center, the Department of Medicine, and.
Can E SenkalFrom the Stony Brook Cancer Center, the Department of Medicine, and.
Jae Kyo YiFrom the Stony Brook Cancer Center, the Department of Medicine, and.
Cungui MaoFrom the Stony Brook Cancer Center, the Department of Medicine, and.
Chiara LubertoFrom the Stony Brook Cancer Center, the Department of Physiology and Biophysics, Stony Brook University, Health Sciences Center, Stony Brook, New York 11794 and.
Yusuf A HannunFrom the Stony Brook Cancer Center, the Department of Medicine, and.
Lina M ObeidFrom the Stony Brook Cancer Center, the Department of Medicine, and the Northport Veterans Affairs Medical Center, Northport, New York 11768 lina.obeid@stonybrookmedicine.edu.
Stony Brook University · USNorthport VA Medical Center · US

Funding

Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI Daniel Canals · 2003 to 2026
$30.8M
Role and Regulation of Ceramide Synthases in ApoptosisR01GM097741 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI LUBERTO, CHIARA · 2011 to 2019
$3.5M
The Role of Ceramidases in Cancer ChemotherapyR01CA163825 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI MAO, CUNGUI · 2012 to 2016
$1.6M
Regulation and Role of Ceramidase in InflammationI01BX000156 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI OBEID, LINA M · 2009 to 2017
–
BLRD VA I01 BX000156NCI NIH HHS P01 CA097132NCI NIH HHS P01CA097132NCI NIH HHS R01 CA163825NIGMS NIH HHS GM097741NIGMS NIH HHS R01 GM097741
6 · The paper itself

Abstract

Ceramide synthases (CerS1-CerS6), which catalyze the N-acylation of the (dihydro)sphingosine backbone to produce (dihydro)ceramide in both the de novo and the salvage or recycling pathway of ceramide generation, have been implicated in the control of programmed cell death. However, the regulation of the de novo pathway compared with the salvage pathway is not fully understood. In the current study, we have found that late accumulation of multiple ceramide and dihydroceramide species in MCF-7 cells treated with TNFα occurred by up-regulation of both pathways of ceramide synthesis. Nevertheless, fumonisin B1 but not myriocin was able to protect from TNFα-induced cell death, suggesting that ceramide synthase activity is crucial for the progression of cell death and that the pool of ceramide involved derives from the salvage pathway rather than de novo biosynthesis. Furthermore, compared with control cells, TNFα-treated cells exhibited reduced focal adhesion kinase and subsequent plasma membrane permeabilization, which was blocked exclusively by fumonisin B1. In addition, exogenously added C6-ceramide mimicked the effects of TNFα that lead to cell death, which were inhibited by fumonisin B1. Knockdown of individual ceramide synthases identified CerS6 and its product C16-ceramide as the ceramide synthase isoform essential for the regulation of cell death. In summary, our data suggest a novel role for CerS6/C16-ceramide as an upstream effector of the loss of focal adhesion protein and plasma membrane permeabilization, via the activation of caspase-7, and identify the salvage pathway as the critical mechanism of ceramide generation that controls cell death.

Indexed as

ApoptosisCaspasesCeramidesEnzyme ActivationFocal Adhesion Protein-Tyrosine KinasesFumonisinsGene Knockdown TechniquesHumansMCF-7 CellsOxidoreductasesTumor Necrosis Factor-alphaCaspasesCeramidesdihydroceramide desaturaseFocal Adhesion Protein-Tyrosine Kinasesfumonisin B1FumonisinsOxidoreductasesTumor Necrosis Factor-alphacell deathCeramideceramide synthasefumonisin b1plasma membranePTK2 protein tyrosine kinase 2 (PTK2) (focal adhesion kinase) (FAK)sphingolipid

Identifiers

PMID26318452
PMCPMC4646185
OpenAlexW2239495151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.